Derek J. Nancarrow

4.0k citations

67 papers · 1.9k indexed · h-index 26

Molecular Biology top 10%
Oncology top 5%
Cancer Research top 5%
Surgery top 10%
Genetics top 10%

Co-authors: Nicholas K. Hayward David C. Whiteman Marilyn K. Walters Mitchell Stark Marion A. Maw Jane M. Palmer David I. Watson Bryan Mowry
Topics: Esophageal Cancer Research and Treatment (15 papers)Cancer Genomics and Diagnostics (10 papers)Genomic variations and chromosomal abnormalities (9 papers)
Cited by: Cancer Research Oncology Ophthalmology
Journals: The Lancet Nucleic Acids Research Journal of Biological Chemistry
Partner nations: Australia United States India

In The Last Decade

Derek J. Nancarrow

65 papers receiving 1.9k citations

Peers

Countries citing papers authored by Derek J. Nancarrow

Since Specialization

Citations

This map shows the geographic impact of Derek J. Nancarrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek J. Nancarrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek J. Nancarrow more than expected).

Fields of papers citing papers by Derek J. Nancarrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek J. Nancarrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek J. Nancarrow. The network helps show where Derek J. Nancarrow may publish in the future.

Co-authorship network of co-authors of Derek J. Nancarrow

This figure shows the co-authorship network connecting the top 25 collaborators of Derek J. Nancarrow. A scholar is included among the top collaborators of Derek J. Nancarrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek J. Nancarrow. Derek J. Nancarrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SMURF2 Facilitates GAP17 Isoform 1 Membrane Displacement to Promote Mutant p53–KRAS Oncogenic Synergy 2025 ·Molecular Cancer Research ·Paramita Ray,Shirish Shukla,Yaqing Zhang,Katelyn L. Donahue,Derek J. Nancarrow,(unknown),Sunita Shankar,Kyle C. Cuneo,Dafydd G. Thomas,Shirish M. Gadgeel,Theodore S. Lawrence,Marina Pasca di Magliano,Dipankar Ray	0
2	GRAIL1 Stabilizes Misfolded Mutant p53 through a Ubiquitin Ligase-Independent, Chaperone Regulatory Function 2024 ·Molecular Cancer Research ·Paramita Ray,Sangeeta Jaiswal,Daysha Ferrer-Torres,(unknown),Derek J. Nancarrow,(unknown),(unknown),(unknown),(unknown),Dafydd G. Thomas,Jason R. Spence,Matthias C. Truttmann,Kiran H. Lagisetty,Theodore S. Lawrence,Thomas D. Wang,David G. Beer,Dipankar Ray	0
3	ISG15/GRAIL1/CD3 axis influences survival of patients with esophageal adenocarcinoma 2024 ·JCI Insight ·Dyke P. McEwen,Paramita Ray,Derek J. Nancarrow,Zhuwen Wang,(unknown),(unknown),(unknown),(unknown),Dafydd G. Thomas,Theodore S. Lawrence,David G. Beer,Kiran H. Lagisetty,Dipankar Ray	2
4	The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity 2020 ·Journal of Biological Chemistry ·Wei Huang,Paramita Ray,Wenbin Ji,Zhuwen Wang,Derek J. Nancarrow,Guoan Chen,Stefanie Galbán,Theodore S. Lawrence,David G. Beer,Alnawaz Rehemtulla,Nithya Ramnath,Dipankar Ray	6
5	Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable Esophageal Adenocarcinoma 2018 ·Journal of Surgical Research ·Brendan T. Heiden,(unknown),Derek J. Nancarrow,(unknown),Richard K. Brown,Mark B. Orringer,Jules Lin,Andrew C. Chang,Philip W. Carrott,William R. Lynch,Lili Zhao,David G. Beer,Rishindra M. Reddy	7
6	Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma 2015 ·Molecular & Cellular Proteomics ·Alok K. Shah,Kim‐Anh Lê Cao,Eun‐Ju Choi,David Chen,Benoît Gautier,Derek J. Nancarrow,David C. Whiteman,Nicholas A. Saunders,Andrew P. Barbour,Virendra Joshi,Michelle M. Hill	29
7	Identification of TFG (TRK‐fused gene) as a putative metastatic melanoma tumor suppressor gene 2012 ·Genes Chromosomes and Cancer ·Ken Dutton‐Regester,Lauren G. Aoude,Derek J. Nancarrow,Mitchell Stark,Linda O’Connor,Cathy Lanagan,Gulietta M. Pupo,Varsha Tembe,(unknown),Michael G. E. OʼRourke,Richard A. Scolyer,Graham J. Mann,Christopher Schmidt,Adrian C. Herington,Nicholas K. Hayward	24
8	Whole Genome Expression Array Profiling Highlights Differences in Mucosal Defense Genes in Barrett's Esophagus and Esophageal Adenocarcinoma 2011 ·PLoS ONE ·Derek J. Nancarrow,Andrew D. Clouston,B. Mark Smithers,D. C. Gotley,Paul A. Drew,David I. Watson,Sonika Tyagi,Nicholas K. Hayward,David C. Whiteman,(unknown)	35
9	Barrett's esophagus 2010 ·Journal of Gastroenterology and Hepatology ·Wayne A. Phillips,Reginald V. Lord,Derek J. Nancarrow,David I. Watson,David C. Whiteman	45
10	Gene expression alterations in formalin-fixed, paraffin-embedded Barrett esophagus and esophageal adenocarcinoma tissues. 2010 ·Cancer Biology & Therapy ·Natalia K. Botelho,(unknown),Sarah J. Lord,(unknown),Sonika Tyagi,Derek J. Nancarrow,Nicholas K. Hayward,David C. Whiteman,Reginald V. Lord	18
11	Genome-Wide Copy Number Analysis in Esophageal Adenocarcinoma Using High-Density Single-Nucleotide Polymorphism Arrays 2008 ·Cancer Research ·Derek J. Nancarrow,Herlina Y. Handoko,B. Mark Smithers,D. C. Gotley,Paul A. Drew,David I. Watson,Andrew D. Clouston,Nicholas K. Hayward,David C. Whiteman,(unknown)	65
12	Gene Promoter Methylation of ID4 and ARL4D in Barrett's Esophagus and Esophageal Adenocarcinoma 2006 ·Gastroenterology ·Eric Smith,Derek J. Nancarrow,Sandra Pavey,Nicholas K. Hayward,(unknown),John J. Kelly,David C. Whiteman,(unknown),D. C. Gotley,Paul A. Drew	1
13	Genetic homogeneity for inherited congenital microcoria loci in an Asian Indian pedigree. 2005 ·PubMed ·Vedam L. Ramprasad,Sarangapani Sripriya,Ronnie George,Derek J. Nancarrow,Sandeep Saxena,Hemamalini Arvind,Dipak Kumar,Lingam Vijaya,Govindasamy Kumaramanickavel	9
14	Mutation of the gene encoding cellular retinaldehyde–binding protein in autosomal recessive retinitis pigmentosa 1997 ·Nature Genetics ·Marion A. Maw,Breandán N. Kennedy,Allison Knight,(unknown),Karen E. Roth,Elisa Mani,J K Mukkadan,Derek J. Nancarrow,John W. Crabb,Michael J. Denton	258
15	Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma 1994 ·International Journal of Cancer ·Graeme J. Walker,Jane M. Palmer,Marilyn K. Walters,Derek J. Nancarrow,Peter G. Parsons,Nicholas K. Hayward	44
16	Linkage analysis in familial melanoma kindreds to markers on chromosome 6p 1994 ·International Journal of Cancer ·Graeme J. Walker,Derek J. Nancarrow,Marilyn K. Walters,Jane M. Palmer,James L. Weber,Nicholas K. Hayward	26
17	Exclusion of the familial melanoma locus (MLM) from the PNDD1S47 and MYCL1 regions of chromosome arm 1p in 7 Australian pedigrees 1992 ·Genomics ·Derek J. Nancarrow,Jane M. Palmer,Marilyn K. Walters,(unknown),Gregory J. Hafner,Luke Garske,G. Roderick McLeod,Nicholas K. Hayward	39
18	Detection of somatic mutations in tumours of diverse types by DNA fingerprinting with M13 phage DNA 1990 ·International Journal of Cancer ·Nicholas K. Hayward,Philip Chen,Derek J. Nancarrow,John H. Kearsley,Peter J. Smith,Chev Kidson,K.A.O. Ellem	9
19	TaqI polymorphism within the c-Ha-ras-1 VTR is associated with melanoma 1989 ·Human Genetics ·Nicholas K. Hayward,Derek J. Nancarrow,Peter G. Parsons,C Kidson,K.A.O. Ellem	4
20	c-Ha-ras-1 alleles in bladder cancer, Wilms' tumour and malignant melanoma 1988 ·Human Genetics ·Nicholas K. Hayward,(unknown),Derek J. Nancarrow,Melissa H. Little,Peter J. Smith,Robert A. Gardiner,G. J. Seymour,C Kidson,Martin F. Lavin	25

About Derek J. Nancarrow

Derek J. Nancarrow is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 67 papers that have together received 1.9k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (15 papers), Cancer Genomics and Diagnostics (10 papers) and Genomic variations and chromosomal abnormalities (9 papers). The work is most often cited by research in Cancer Research (388 citations), Oncology (506 citations) and Ophthalmology (160 citations). Derek J. Nancarrow has collaborated with scholars based in Australia, United States and India. Frequent co-authors include Nicholas K. Hayward, David C. Whiteman, Marilyn K. Walters, Mitchell Stark, Marion A. Maw, Jane M. Palmer, David I. Watson, Bryan Mowry, Christopher Schmidt and Peter G. Parsons. Their work appears in journals such as The Lancet, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact